Literature DB >> 34910941

Integrins and their role in megakaryocyte development and function.

Xiaosheng Yang1, Shlok V Chitalia1, Shinobu Matsuura1, Katya Ravid2.   

Abstract

Mature megakaryocytes, the platelet precursors, originate from hematopoietic stem cell progenitors, which, once committed to this lineage, undergo endomitosis leading to polyploidization. The process entails repeated rounds of DNA replication without cell division, yielding polyploid cells. Supporting the cell's developmental process and various cellular functions are integrin receptors, a conduit of communication between the extracellular environment and the cell actin cytoskeleton. Integrins are heterodimers of α and β subunits, where different combinations of the known 18 α and 8 β subunits confer specificity to the receptor. Integrin ligands range from extracellular matrices through soluble ligands, infectious agents, and counterreceptors, to cells. In this review, we describe the different integrins expressed on bone marrow megakaryocytes and their attributed roles in lineage development and cellular functions, including adhesion, spreading, proplatelet formation, and functional interaction with other cells. Pathologies associated with dysregulated megakaryocyte integrin expression are also reviewed.
Copyright © 2021 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34910941      PMCID: PMC8795491          DOI: 10.1016/j.exphem.2021.11.007

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.249


  76 in total

Review 1.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

2.  Overexpression of the partially activated alpha(IIb)beta3D723H integrin salt bridge mutant downregulates RhoA activity and induces microtubule-dependent proplatelet-like extensions in Chinese hamster ovary cells.

Authors:  E Schaffner-Reckinger; A Salsmann; N Debili; J Bellis; J De Mey; W Vainchenker; W H Ouwehand; N Kieffer
Journal:  J Thromb Haemost       Date:  2009-05-22       Impact factor: 5.824

Review 3.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 4.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Properties of the K562 cell line derived from a patient with chronic myeloid leukemia.

Authors:  B B Lozzio; C B Lozzio
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

Review 6.  Extracellular matrix receptors and the differentiation of human megakaryocytes in vitro.

Authors:  A Molla; P Mossuz; R Berthier
Journal:  Leuk Lymphoma       Date:  1999-03

7.  Adhesion to fibronectin via α5β1 integrin supports expansion of the megakaryocyte lineage in primary myelofibrosis.

Authors:  Shinobu Matsuura; Cristal Reyna Thompson; Seng Kah Ng; Christina Marie Ward; Aikaterini Karagianni; Carla Mazzeo; Alessandro Malara; Alessandra Balduini; Katya Ravid
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

8.  Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation.

Authors:  Ying-Hua Cheng; R Adam Hooker; Khanh Nguyen; Rita Gerard-O'Riley; David L Waning; Brahmananda R Chitteti; Tomas E Meijome; Hui Lin Chua; Artur P Plett; Christie M Orschell; Edward F Srour; Lindsey D Mayo; Fredrick M Pavalko; Angela Bruzzaniti; Melissa A Kacena
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

9.  Laminin receptor on platelets is the integrin VLA-6.

Authors:  A Sonnenberg; P W Modderman; F Hogervorst
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

10.  Conditional knockout of integrin α2β1 in murine megakaryocytes leads to reduced mean platelet volume.

Authors:  David Habart; Yann Cheli; Diane J Nugent; Zaverio M Ruggeri; Thomas J Kunicki
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.